401k Plan data: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN plan

MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 401k Plan overview

Plan Name	MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN
Plan identification number	001

MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

CURIUM US LLC has sponsored the creation of one or more 401k plans.

Company Name: CURIUM US LLC

Employer identification number (EIN): 472088928

NAIC Classification: 325410

Additional information about CURIUM US LLC

Jurisdiction of Incorporation: State of Delaware Division of Corporations

Incorporation Date:

Company Identification Number: 5608631

More information about CURIUM US LLC

Form 5500 Filing Information

Submission information for form 5500 for 401k plan MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-03-06 CAROL SVEJKOSKY, CFO

Plan Statistics for MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN

401k plan membership statisitcs for MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN

Measure Date Value
2022: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 609
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 513
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 184
Total of all active and inactive participants 2022-01-01 697
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 2
Total participants 2022-01-01 699
Number of participants with account balances 2022-01-01 695
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 35
2021: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 527
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 465
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 143
Total of all active and inactive participants 2021-01-01 608
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 1
Total participants 2021-01-01 609
Number of participants with account balances 2021-01-01 609
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 21
2020: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 464
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 430
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 96
Total of all active and inactive participants 2020-01-01 526
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 1
Total participants 2020-01-01 527
Number of participants with account balances 2020-01-01 527
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 13
2019: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 442
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 392
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 71
Total of all active and inactive participants 2019-01-01 463
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 1
Total participants 2019-01-01 464
Number of participants with account balances 2019-01-01 464
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 6
2018: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 412
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 392
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 50
Total of all active and inactive participants 2018-01-01 442
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 442
Number of participants with account balances 2018-01-01 431
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 5
2017: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2017 401k membership
Total participants, beginning-of-year 2017-03-06 0
Total number of active participants reported on line 7a of the Form 5500 2017-03-06 377
Number of retired or separated participants receiving benefits 2017-03-06 0
Number of other retired or separated participants entitled to future benefits 2017-03-06 29
Total of all active and inactive participants 2017-03-06 406
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-03-06 0
Total participants 2017-03-06 406
Number of participants with account balances 2017-03-06 399
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-03-06 2

Measure	Date	Value
2022: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	609
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	513
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	184
Total of all active and inactive participants	2022-01-01	697
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	2
Total participants	2022-01-01	699
Number of participants with account balances	2022-01-01	695
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	35
2021: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	527
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	465
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	143
Total of all active and inactive participants	2021-01-01	608
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	1
Total participants	2021-01-01	609
Number of participants with account balances	2021-01-01	609
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	21
2020: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	464
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	430
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	96
Total of all active and inactive participants	2020-01-01	526
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	1
Total participants	2020-01-01	527
Number of participants with account balances	2020-01-01	527
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	13
2019: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	442
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	392
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	71
Total of all active and inactive participants	2019-01-01	463
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	1
Total participants	2019-01-01	464
Number of participants with account balances	2019-01-01	464
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	6
2018: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	412
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	392
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	50
Total of all active and inactive participants	2018-01-01	442
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	442
Number of participants with account balances	2018-01-01	431
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	5
2017: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2017 401k membership
Total participants, beginning-of-year	2017-03-06	0
Total number of active participants reported on line 7a of the Form 5500	2017-03-06	377
Number of retired or separated participants receiving benefits	2017-03-06	0
Number of other retired or separated participants entitled to future benefits	2017-03-06	29
Total of all active and inactive participants	2017-03-06	406
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-03-06	0
Total participants	2017-03-06	406
Number of participants with account balances	2017-03-06	399
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-03-06	2

Financial Data on MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN

Measure	Date	Value
2022 : MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2022 401k financial data
Total income from all sources (including contributions)	2022-12-31	$-3,513,371
Total of all expenses incurred	2022-12-31	$5,227,480
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$5,139,038
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$7,580,991
Value of total assets at end of year	2022-12-31	$56,888,286
Value of total assets at beginning of year	2022-12-31	$65,629,137
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$88,442
Total interest from all sources	2022-12-31	$46,258
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$1,284,499
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$1,284,499
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$4,245,339
Participant contributions at end of year	2022-12-31	$1,200,883
Participant contributions at beginning of year	2022-12-31	$1,316,883
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$481,457
Value of other receiveables (less allowance for doubtful accounts) at end of year	2022-12-31	$1,299
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2022-12-31	$1,473
Administrative expenses (other) incurred	2022-12-31	$88,442
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-8,740,851
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$56,888,286
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$65,629,137
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$55,686,104
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$64,310,781
Interest on participant loans	2022-12-31	$46,258
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-12,425,119
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$2,854,195
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$5,139,038
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2022-12-31	No
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	ARMANINO, LLP
Accountancy firm EIN	2022-12-31	946214841
2021 : MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2021 401k financial data
Total income from all sources (including contributions)	2021-12-31	$15,366,357
Total of all expenses incurred	2021-12-31	$3,624,880
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$3,537,703
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$7,257,575
Value of total assets at end of year	2021-12-31	$65,629,137
Value of total assets at beginning of year	2021-12-31	$53,887,660
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$87,177
Total interest from all sources	2021-12-31	$47,194
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$996,713
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$996,713
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$3,837,005
Participant contributions at end of year	2021-12-31	$1,316,883
Participant contributions at beginning of year	2021-12-31	$1,255,447
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$869,839
Value of other receiveables (less allowance for doubtful accounts) at end of year	2021-12-31	$1,473
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2021-12-31	$5,461
Administrative expenses (other) incurred	2021-12-31	$87,177
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$11,741,477
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$65,629,137
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$53,887,660
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$64,310,781
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$52,626,752
Interest on participant loans	2021-12-31	$47,194
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$7,064,875
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$2,550,731
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$3,537,703
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2021-12-31	No
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	ARMANINO, LLP
Accountancy firm EIN	2021-12-31	946214841
2020 : MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2020 401k financial data
Total income from all sources (including contributions)	2020-12-31	$14,180,121
Total of all expenses incurred	2020-12-31	$4,825,571
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$4,756,227
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$6,736,183
Value of total assets at end of year	2020-12-31	$53,887,660
Value of total assets at beginning of year	2020-12-31	$44,533,110
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$69,344
Total interest from all sources	2020-12-31	$54,717
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$833,286
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$833,286
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$3,500,874
Participant contributions at end of year	2020-12-31	$1,255,447
Participant contributions at beginning of year	2020-12-31	$1,292,482
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$891,319
Value of other receiveables (less allowance for doubtful accounts) at end of year	2020-12-31	$5,461
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2020-12-31	$3,930
Administrative expenses (other) incurred	2020-12-31	$69,344
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$9,354,550
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$53,887,660
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$44,533,110
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$52,626,752
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$43,236,698
Interest on participant loans	2020-12-31	$54,717
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$6,555,935
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$2,343,990
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$4,756,227
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2020-12-31	No
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	ARMANINO,LLP
Accountancy firm EIN	2020-12-31	946214841
2019 : MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2019 401k financial data
Total income from all sources (including contributions)	2019-12-31	$13,486,758
Total of all expenses incurred	2019-12-31	$2,823,112
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$2,739,115
Value of total corrective distributions	2019-12-31	$8,669
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$5,601,518
Value of total assets at end of year	2019-12-31	$44,533,110
Value of total assets at beginning of year	2019-12-31	$33,869,464
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$75,328
Total interest from all sources	2019-12-31	$49,028
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$894,623
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$894,623
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$2,500,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$3,129,245
Participant contributions at end of year	2019-12-31	$1,292,482
Participant contributions at beginning of year	2019-12-31	$1,215,629
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$353,113
Value of other receiveables (less allowance for doubtful accounts) at end of year	2019-12-31	$3,930
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2019-12-31	$2,131
Administrative expenses (other) incurred	2019-12-31	$75,328
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$10,663,646
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$44,533,110
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$33,869,464
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$43,236,698
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$32,651,704
Interest on participant loans	2019-12-31	$49,028
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$6,941,589
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$2,119,160
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$2,739,115
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2019-12-31	No
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	BROWN SMITH WALLACE
Accountancy firm EIN	2019-12-31	431001367
2018 : MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2018 401k financial data
Total income from all sources (including contributions)	2018-12-31	$3,815,912
Total of all expenses incurred	2018-12-31	$2,865,288
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$2,778,636
Value of total corrective distributions	2018-12-31	$13,415
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$6,071,108
Value of total assets at end of year	2018-12-31	$33,869,464
Value of total assets at beginning of year	2018-12-31	$32,918,840
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$73,237
Total interest from all sources	2018-12-31	$48,876
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$749,888
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$749,888
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$2,500,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$3,028,080
Participant contributions at end of year	2018-12-31	$1,215,629
Participant contributions at beginning of year	2018-12-31	$1,353,702
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$977,631
Value of other receiveables (less allowance for doubtful accounts) at end of year	2018-12-31	$2,131
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2018-12-31	$0
Administrative expenses (other) incurred	2018-12-31	$73,237
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$950,624
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$33,869,464
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$32,918,840
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$32,651,704
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$31,565,138
Interest on participant loans	2018-12-31	$48,876
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-3,053,960
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$2,065,397
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$2,778,636
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2018-12-31	No
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	BROWN SMITH WALLACE
Accountancy firm EIN	2018-12-31	431001367
2017 : MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2017 401k financial data
Total transfer of assets to this plan	2017-12-31	$1,211,964
Total income from all sources (including contributions)	2017-12-31	$33,037,650
Total of all expenses incurred	2017-12-31	$1,330,774
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$1,265,936
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$29,960,800
Value of total assets at end of year	2017-12-31	$32,918,840
Value of total assets at beginning of year	2017-12-31	$0
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$64,838
Total interest from all sources	2017-12-31	$30,739
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$471,197
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$471,197
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$2,500,000
If this is an individual account plan, was there a blackout period	2017-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$2,171,408
Participant contributions at end of year	2017-12-31	$1,353,702
Participant contributions at beginning of year	2017-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$26,287,169
Administrative expenses (other) incurred	2017-12-31	$64,838
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$31,706,876
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$32,918,840
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$0
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$31,565,138
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$0
Interest on participant loans	2017-12-31	$30,739
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$2,574,914
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$1,502,223
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$1,265,936
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2017-12-31	Yes
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	BROWN SMITH WALLACE
Accountancy firm EIN	2017-12-31	431001367

Form 5500 Responses for MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN

2022: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: MALLINCKRODT NUCLEAR MEDICINE, LLC 401K PLAN 2017 form 5500 responses
2017-03-06	Type of plan entity	Single employer plan
2017-03-06	First time form 5500 has been submitted	Yes
2017-03-06	This return/report is a short plan year return/report (less than 12 months)	Yes
2017-03-06	Plan funding arrangement – Trust	Yes
2017-03-06	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	CURIUM US LLC
Employer identification number (EIN):	472088928
NAIC Classification:	325410

Jurisdiction of Incorporation:	State of Delaware Division of Corporations
Incorporation Date:
Company Identification Number:	5608631